Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-104 in Type 2 Diabetes Inadequately Controlled on Metformin
NCT00525330Phase 2Completed
- Sponsor
- ActivX Biosciences, Inc.
- Start
- Sep 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by ActivX Biosciences, Inc.. Started Sep 2007; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00525330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525330.